![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Viropro, ProteoCell Biotechnologies Sign Collaboration Agreement
Viropro, ProteoCell Biotechnologies Sign Collaboration Agreement
Viropro Pharma Inc., a subsidiary of Viropro Inc., and ProteoCell Biotechnologies Inc. have signed a collaboration agreement to co-commercialize specific recombinant biogeneric biotherapeutics for international markets. Specializing in the commercialization of biopharmaceutical products, Viropro Pharma previously acquired licenses from Tokyo-based ImmunoJapan Inc. (IJI) for patented protein production technologies related to specific therapeutics.
Yahoo News (http://biz.yahoo.com/pz/050315/74481.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct